Matches in SemOpenAlex for { <https://semopenalex.org/work/W12145801> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W12145801 endingPage "8" @default.
- W12145801 startingPage "185" @default.
- W12145801 abstract "120 chemotherapy naive patients were treated with gemcitabine 1250 mg/m2 iv. days 1 and 8 and cisplatin 70 mg/m2 iv. on day 1 between May 1999 and June 2001. The treatments were administered in 21 cycles. The median age of the patients was 53.1 years, the male/female ratio 65%-35%. Performance status was: WHO 0: 26%, WHO 1: 74%. The staging of patients were: IIIA-N2 23%, IIIB 37%, IV 40%. By histology the tumors were: 53.3% adenocarcinoma, 40% squamous cell carcinoma, 2.5% adenosquamous carcinoma, 0.8% macrocellular carcinoma and 3% non-small cell carcinoma (not categorised). We evaluated 413 cycles of chemotherapy. The median number of cycles was 3.44. The primary endpoint of the study was the median survival and time to progression, and the response rate. The results are the following: RR 40% (PR 37.5%, CR 2.5%), MR 13.3%, SD 25%, PD 22%. The time to progression (TTP) in the SD+MR group: 29.8 weeks, in the RR group: 34.1 weeks, mean of all patients: 28.1 weeks. The survival time was estimated by Kaplan-Meier curves. The median survival (MS) of all treated patients was: 54.9 weeks, in the PD group: 34.4 weeks, in the SD+MR group: 59.1 weeks, in the PR+CR group: 62.1 weeks.gemcitabine and cisplatin combination is a very well tolerated therapeutic regimen in the 1st line treatment of NSCLC. Furthermore, this treatment improves the RR and the survival of the patients as well." @default.
- W12145801 created "2016-06-24" @default.
- W12145801 creator A5001235772 @default.
- W12145801 creator A5016276581 @default.
- W12145801 creator A5020822985 @default.
- W12145801 creator A5028746264 @default.
- W12145801 creator A5038943836 @default.
- W12145801 creator A5064195316 @default.
- W12145801 creator A5091474160 @default.
- W12145801 date "2003-01-01" @default.
- W12145801 modified "2023-10-18" @default.
- W12145801 title "[Effectiveness of Gemzar-Cisplatin therapy in stage IIIA-N2, IIIB and IV non-small cell lung cancer]." @default.
- W12145801 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12975667" @default.
- W12145801 hasPublicationYear "2003" @default.
- W12145801 type Work @default.
- W12145801 sameAs 12145801 @default.
- W12145801 citedByCount "0" @default.
- W12145801 crossrefType "journal-article" @default.
- W12145801 hasAuthorship W12145801A5001235772 @default.
- W12145801 hasAuthorship W12145801A5016276581 @default.
- W12145801 hasAuthorship W12145801A5020822985 @default.
- W12145801 hasAuthorship W12145801A5028746264 @default.
- W12145801 hasAuthorship W12145801A5038943836 @default.
- W12145801 hasAuthorship W12145801A5064195316 @default.
- W12145801 hasAuthorship W12145801A5091474160 @default.
- W12145801 hasConcept C121608353 @default.
- W12145801 hasConcept C126322002 @default.
- W12145801 hasConcept C126894567 @default.
- W12145801 hasConcept C143998085 @default.
- W12145801 hasConcept C146357865 @default.
- W12145801 hasConcept C151730666 @default.
- W12145801 hasConcept C2776256026 @default.
- W12145801 hasConcept C2776283816 @default.
- W12145801 hasConcept C2776512503 @default.
- W12145801 hasConcept C2776694085 @default.
- W12145801 hasConcept C2777546739 @default.
- W12145801 hasConcept C2778239845 @default.
- W12145801 hasConcept C2780258809 @default.
- W12145801 hasConcept C2781182431 @default.
- W12145801 hasConcept C2781413609 @default.
- W12145801 hasConcept C71924100 @default.
- W12145801 hasConcept C86803240 @default.
- W12145801 hasConcept C90924648 @default.
- W12145801 hasConceptScore W12145801C121608353 @default.
- W12145801 hasConceptScore W12145801C126322002 @default.
- W12145801 hasConceptScore W12145801C126894567 @default.
- W12145801 hasConceptScore W12145801C143998085 @default.
- W12145801 hasConceptScore W12145801C146357865 @default.
- W12145801 hasConceptScore W12145801C151730666 @default.
- W12145801 hasConceptScore W12145801C2776256026 @default.
- W12145801 hasConceptScore W12145801C2776283816 @default.
- W12145801 hasConceptScore W12145801C2776512503 @default.
- W12145801 hasConceptScore W12145801C2776694085 @default.
- W12145801 hasConceptScore W12145801C2777546739 @default.
- W12145801 hasConceptScore W12145801C2778239845 @default.
- W12145801 hasConceptScore W12145801C2780258809 @default.
- W12145801 hasConceptScore W12145801C2781182431 @default.
- W12145801 hasConceptScore W12145801C2781413609 @default.
- W12145801 hasConceptScore W12145801C71924100 @default.
- W12145801 hasConceptScore W12145801C86803240 @default.
- W12145801 hasConceptScore W12145801C90924648 @default.
- W12145801 hasIssue "2" @default.
- W12145801 hasLocation W121458011 @default.
- W12145801 hasOpenAccess W12145801 @default.
- W12145801 hasPrimaryLocation W121458011 @default.
- W12145801 hasRelatedWork W2031554341 @default.
- W12145801 hasRelatedWork W2349270370 @default.
- W12145801 hasRelatedWork W2356915734 @default.
- W12145801 hasRelatedWork W2361287035 @default.
- W12145801 hasRelatedWork W2367470826 @default.
- W12145801 hasRelatedWork W2369279113 @default.
- W12145801 hasRelatedWork W2370159089 @default.
- W12145801 hasRelatedWork W2381460883 @default.
- W12145801 hasRelatedWork W2442673159 @default.
- W12145801 hasRelatedWork W2093038496 @default.
- W12145801 hasVolume "47" @default.
- W12145801 isParatext "false" @default.
- W12145801 isRetracted "false" @default.
- W12145801 magId "12145801" @default.
- W12145801 workType "article" @default.